Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Nicotine dependence pharmacogenetics: role of genetic variation in nicotine-metabolizing enzymes.

Journal of neurogenetics - 1 Jan 2009

Ray Riju, Tyndale Rachel F, Lerman Caryn

Abstract excerpt

Nicotine-dependence pharmacogenetics research is an emerging field, and a number of studies have begun to characterize the clinical relevance and predictive power of genetic variation in drug-metabolizing enzymes and drug target genes for response to medication. The present paper focuses on evidence for the role of nicotine-metabolizing enzymes in smoking behavior and response to treatment. Nicotine metabolism is...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antidepressive Agents, Second-Generation
Share to Aryl Hydrocarbon Hydroxylases

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Bupropion

Share to Cytochrome P-450 CYP2A6

Share to Genetic Association Studies

Share to Nicotine

Share to Pharmacogenetics

Share to Tobacco Use Disorder

Source

Open in PubMed Open full text

Identifiers

PMID: 19169923
DOI: 10.1080/01677060802572887
PMCID: PMC3772540

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Nicotine dependence pharmacogenetics: role of genetic variation in nicotine-metabolizing enzymes.PMID 19169923Read ↗

Genetic variability in CYP2A6 and the pharmacokinetics of nicotine.Semantic proximity Read ↗

The Role of Pharmacogenetics in Smoking.Semantic proximity Read ↗

Genetic variation in CYP2A6-mediated nicotine metabolism alters smoking behavior.Semantic proximity Read ↗

Drugs and genotypes: how pharmacogenetic information could improve smoking cessation treatment.Semantic proximity Read ↗

Smoking behavior and related cancers: the role of CYP2A6 polymorphisms.Semantic proximity Read ↗

Determinants of the rate of nicotine metabolism and effects on smoking behavior.Semantic proximity Read ↗

CYP2B6 gene single-nucleotide polymorphisms in an Italian population sample and relationship with nicotine dependence.Semantic proximity Read ↗

Pharmacogenetics and nicotine addiction treatment.Semantic proximity Read ↗

Genetic influences on smoking: a brief review.Semantic proximity Read ↗

Disposition kinetics and metabolism of nicotine and cotinine in African American smokers: impact of CYP2A6 genetic variation and enzymatic activity.Semantic proximity Read ↗

Nicotine Metabolism Predicted by CYP2A6 Genotypes in Relation to Smoking Cessation: A Systematic Review.Semantic proximity Read ↗

Clinical pharmacology of nicotine: implications for understanding, preventing, and treating tobacco addiction.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.